HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

Hepatitis C virus (HCV) antiviral treatment for people who inject drugs (PWID) could prevent onwards transmission and reduce chronic prevalence. We assessed current PWID treatment rates in seven UK settings and projected the potential impact of current and scaled-up treatment on HCV chronic prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, N K, Foster, G R, Vilar, J, Ryder, S, E Cramp, M, Gordon, F, Dillon, J F, Craine, N, Busse, H, Clements, A, Hutchinson, S J, Ustianowski, A, Ramsay, M, Goldberg, D J, Irving, W, Hope, V, De Angelis, D, Lyons, M, Vickerman, P, Hickman, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409099/
https://www.ncbi.nlm.nih.gov/pubmed/25288193
http://dx.doi.org/10.1111/jvh.12338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409099/
https://www.ncbi.nlm.nih.gov/pubmed/25288193
http://dx.doi.org/10.1111/jvh.12338

Ejemplares similares